Ulrike Hövelmann, MD
Profil Institut für Stoffwechselforschung GmbH
4
4
4
N/A
0
1
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Roman Hovorka, PhD
University of Cambridge
Shared therapeutic areas:
Worked with same sponsors:
Mark Christiansen, MD
Diablo Clinical Research
Shared therapeutic areas:
Bruce Buckingham, MD
Stanford University
Shared therapeutic areas:
Bruce Bode, MD
Atlanta Diabetes Associates
Shared therapeutic areas:
Timothy Bailey, MD
AMCR Institute
Shared therapeutic areas:
Kristin Castorino, DO
Sansum Diabetes Research Institute
Shared therapeutic areas:
Michael Roden, Prof., MD
German Diabetes Center
Shared therapeutic areas:
Mustafa H Temel, M.D.
Uskudar State Hospital
Shared therapeutic areas:
Sue Brown, MD
University of Virginia
Shared therapeutic areas:
Rémi Rabasa-Lhoret
Institut de Recherches Cliniques de Montreal
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
Bioavailability of PRUVIN® and Its Effects in Healthy Subjects (INDIGO)
A Trial to Investigate the Safety and the Pharmacokinetic, Pharmacodynamic Characteristics of Two BioChaperone® Glucagon Formulations Compared to Marketed GlucaGen® in Subjects With T1DM
Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin 30/70 and Huminsulin® Profil III
Single Doses of ZP4207 Adm. sc to Hypoglycemic TD1 pt. to Describe the PK and PD of ZP4207 as Comp. to Marketed Glucagon
All 4 trials loaded